 | • レポートコード：GIR-2104Z02296 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ブリナツモマブ薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ブリナツモマブ薬の種類別市場規模（プレフィルド、ノンプレフィルド）、用途別市場規模（病院、薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ブリナツモマブ薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Amgen ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：プレフィルド、ノンプレフィルド ・用途別分析2016年-2026年：病院、薬局 ・ブリナツモマブ薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ブリナツモマブ薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ブリナツモマブ薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ブリナツモマブ薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ブリナツモマブ薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Blinatumomab Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Blinatumomab Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Blinatumomab Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Blinatumomab Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Prefilled
Non-prefilled
Market segment by Application can be divided into
Hospital
Pharmacy
The key market players for global Blinatumomab Drugs market are listed below:
Amgen
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Blinatumomab Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Blinatumomab Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Prefilled
1.2.3 Non-prefilled
1.3 Market Analysis by Application
1.3.1 Overview: Global Blinatumomab Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Blinatumomab Drugs Market Size & Forecast
1.4.1 Global Blinatumomab Drugs Sales in Value (2016-2026))
1.4.2 Global Blinatumomab Drugs Sales in Volume (2016-2026)
1.4.3 Global Blinatumomab Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Blinatumomab Drugs Production Capacity Analysis
1.5.1 Global Blinatumomab Drugs Total Production Capacity (2016-2026)
1.5.2 Global Blinatumomab Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Blinatumomab Drugs Market Drivers
1.6.2 Blinatumomab Drugs Market Restraints
1.6.3 Blinatumomab Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Blinatumomab Drugs Product and Services
2.1.4 Amgen Blinatumomab Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Blinatumomab Drugs Sales by Manufacturer
3.1 Global Blinatumomab Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Blinatumomab Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Blinatumomab Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Blinatumomab Drugs Manufacturer Market Share
3.4.2 Top 6 Blinatumomab Drugs Manufacturer Market Share
3.5 Global Blinatumomab Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Blinatumomab Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Blinatumomab Drugs Market Size by Region
4.1.1 Global Blinatumomab Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Blinatumomab Drugs Revenue by Region (2016-2026)
4.2 North America Blinatumomab Drugs Revenue (2016-2026)
4.3 Europe Blinatumomab Drugs Revenue (2016-2026)
4.4 Asia-Pacific Blinatumomab Drugs Revenue (2016-2026)
4.5 South America Blinatumomab Drugs Revenue (2016-2026)
4.6 Middle East and Africa Blinatumomab Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Blinatumomab Drugs Sales in Volume by Type (2016-2026)
5.2 Global Blinatumomab Drugs Revenue by Type (2016-2026)
5.3 Global Blinatumomab Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Blinatumomab Drugs Sales in Volume by Application (2016-2026)
6.2 Global Blinatumomab Drugs Revenue by Application (2016-2026)
6.3 Global Blinatumomab Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Blinatumomab Drugs Sales by Type (2016-2026)
7.2 North America Blinatumomab Drugs Sales by Application (2016-2026)
7.3 North America Blinatumomab Drugs Market Size by Country
7.3.1 North America Blinatumomab Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Blinatumomab Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Blinatumomab Drugs Sales by Type (2016-2026)
8.2 Europe Blinatumomab Drugs Sales by Application (2016-2026)
8.3 Europe Blinatumomab Drugs Market Size by Country
8.3.1 Europe Blinatumomab Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Blinatumomab Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Blinatumomab Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Blinatumomab Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Blinatumomab Drugs Market Size by Region
9.3.1 Asia-Pacific Blinatumomab Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Blinatumomab Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Blinatumomab Drugs Sales by Type (2016-2026)
10.2 South America Blinatumomab Drugs Sales by Application (2016-2026)
10.3 South America Blinatumomab Drugs Market Size by Country
10.3.1 South America Blinatumomab Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Blinatumomab Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Blinatumomab Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Blinatumomab Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Blinatumomab Drugs Market Size by Country
11.3.1 Middle East & Africa Blinatumomab Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Blinatumomab Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Blinatumomab Drugs Typical Distributors
12.3 Blinatumomab Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Blinatumomab Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Blinatumomab Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Amgen Basic Information, Manufacturing Base and Competitors
Table 4. Amgen Major Business
Table 5. Amgen Blinatumomab Drugs Product and Services
Table 6. Amgen Blinatumomab Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Global Blinatumomab Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 8. Global Blinatumomab Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 9. Market Position of Manufacturers in Blinatumomab Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 10. Global Blinatumomab Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 11. Head Office and Blinatumomab Drugs Production Site of Key Manufacturer
Table 12. Global Blinatumomab Drugs Sales by Region (2016-2021e) & (K Units)
Table 13. Global Blinatumomab Drugs Sales by Region (2021-2026) & (K Units)
Table 14. Global Blinatumomab Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 15. Global Blinatumomab Drugs Revenue by Region (2021-2026) & (USD Million)
Table 16. Global Blinatumomab Drugs Sales by Type (2016-2021e) & (K Units)
Table 17. Global Blinatumomab Drugs Sales by Type (2021-2026) & (K Units)
Table 18. Global Blinatumomab Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 19. Global Blinatumomab Drugs Revenue by Type (2021-2026) & (USD Million)
Table 20. Global Blinatumomab Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 21. Global Blinatumomab Drugs Price by Type (2021-2026) & (USD/Unit)
Table 22. Global Blinatumomab Drugs Sales by Application (2016-2021e) & (K Units)
Table 23. Global Blinatumomab Drugs Sales by Application (2021-2026) & (K Units)
Table 24. Global Blinatumomab Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 25. Global Blinatumomab Drugs Revenue by Application (2021-2026) & (USD Million)
Table 26. Global Blinatumomab Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 27. Global Blinatumomab Drugs Price by Application (2021-2026) & (USD/Unit)
Table 28. North America Blinatumomab Drugs Sales by Country (2016-2021e) & (K Units)
Table 29. North America Blinatumomab Drugs Sales by Country (2021-2026) & (K Units)
Table 30. North America Blinatumomab Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 31. North America Blinatumomab Drugs Revenue by Country (2021-2026) & (USD Million)
Table 32. North America Blinatumomab Drugs Sales by Type (2016-2021e) & (K Units)
Table 33. North America Blinatumomab Drugs Sales by Type (2021-2026) & (K Units)
Table 34. North America Blinatumomab Drugs Sales by Application (2016-2021e) & (K Units)
Table 35. North America Blinatumomab Drugs Sales by Application (2021-2026) & (K Units)
Table 36. Europe Blinatumomab Drugs Sales by Country (2016-2021e) & (K Units)
Table 37. Europe Blinatumomab Drugs Sales by Country (2021-2026) & (K Units)
Table 38. Europe Blinatumomab Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 39. Europe Blinatumomab Drugs Revenue by Country (2021-2026) & (USD Million)
Table 40. Europe Blinatumomab Drugs Sales by Type (2016-2021e) & (K Units)
Table 41. Europe Blinatumomab Drugs Sales by Type (2021-2026) & (K Units)
Table 42. Europe Blinatumomab Drugs Sales by Application (2016-2021e) & (K Units)
Table 43. Europe Blinatumomab Drugs Sales by Application (2021-2026) & (K Units)
Table 44. Asia-Pacific Blinatumomab Drugs Sales by Region (2016-2021e) & (K Units)
Table 45. Asia-Pacific Blinatumomab Drugs Sales by Region (2021-2026) & (K Units)
Table 46. Asia-Pacific Blinatumomab Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 47. Asia-Pacific Blinatumomab Drugs Revenue by Region (2021-2026) & (USD Million)
Table 48. Asia-Pacific Blinatumomab Drugs Sales by Type (2016-2021e) & (K Units)
Table 49. Asia-Pacific Blinatumomab Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Asia-Pacific Blinatumomab Drugs Sales by Application (2016-2021e) & (K Units)
Table 51. Asia-Pacific Blinatumomab Drugs Sales by Application (2021-2026) & (K Units)
Table 52. South America Blinatumomab Drugs Sales by Country (2016-2021e) & (K Units)
Table 53. South America Blinatumomab Drugs Sales by Country (2021-2026) & (K Units)
Table 54. South America Blinatumomab Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 55. South America Blinatumomab Drugs Revenue by Country (2021-2026) & (USD Million)
Table 56. South America Blinatumomab Drugs Sales by Type (2016-2021e) & (K Units)
Table 57. South America Blinatumomab Drugs Sales by Type (2021-2026) & (K Units)
Table 58. South America Blinatumomab Drugs Sales by Application (2016-2021e) & (K Units)
Table 59. South America Blinatumomab Drugs Sales by Application (2021-2026) & (K Units)
Table 60. Middle East & Africa Blinatumomab Drugs Sales by Country (2016-2021e) & (K Units)
Table 61. Middle East & Africa Blinatumomab Drugs Sales by Country (2021-2026) & (K Units)
Table 62. Middle East & Africa Blinatumomab Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 63. Middle East & Africa Blinatumomab Drugs Revenue by Country (2021-2026) & (USD Million)
Table 64. Middle East & Africa Blinatumomab Drugs Sales by Type (2016-2021e) & (K Units)
Table 65. Middle East & Africa Blinatumomab Drugs Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Blinatumomab Drugs Sales by Application (2016-2021e) & (K Units)
Table 67. Middle East & Africa Blinatumomab Drugs Sales by Application (2021-2026) & (K Units)
Table 68. Direct Channel Pros & Cons
Table 69. Indirect Channel Pros & Cons
Table 70. Blinatumomab Drugs Typical Distributors
Table 71. Blinatumomab Drugs Typical Customers
List of Figures
Figure 1. Blinatumomab Drugs Picture
Figure 2. Global Blinatumomab Drugs Sales Market Share by Type in 2020
Figure 3. Prefilled
Figure 4. Non-prefilled
Figure 5. Global Blinatumomab Drugs Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Pharmacy
Figure 8. Global Blinatumomab Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Blinatumomab Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Blinatumomab Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Blinatumomab Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Blinatumomab Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Blinatumomab Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Blinatumomab Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Blinatumomab Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Blinatumomab Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Blinatumomab Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Blinatumomab Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Blinatumomab Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Blinatumomab Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Blinatumomab Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Blinatumomab Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Blinatumomab Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Blinatumomab Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Blinatumomab Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Blinatumomab Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Blinatumomab Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Blinatumomab Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Blinatumomab Drugs Sales (2016-2026) & (K Units)
Figure 30. Global Blinatumomab Drugs Production Capacity (2016-2026) & (K Units)
Figure 31. Global Blinatumomab Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Blinatumomab Drugs Market Drivers
Figure 33. Blinatumomab Drugs Market Restraints
Figure 34. Blinatumomab Drugs Market Trends
Figure 35. Global Blinatumomab Drugs Sales Market Share by Manufacturer in 2020
Figure 36. Global Blinatumomab Drugs Revenue Market Share by Manufacturer in 2020
Figure 37. Blinatumomab Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Blinatumomab Drugs Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Blinatumomab Drugs Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Blinatumomab Drugs Sales Market Share by Region (2016-2026)
Figure 41. Global Blinatumomab Drugs Revenue Market Share by Region (2016-2026)
Figure 42. North America Blinatumomab Drugs Revenue (2016-2026) & (USD Million)
Figure 43. Europe Blinatumomab Drugs Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Blinatumomab Drugs Revenue (2016-2026) & (USD Million)
Figure 45. South America Blinatumomab Drugs Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Blinatumomab Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Global Blinatumomab Drugs Sales Market Share by Type (2016-2026)
Figure 48. Global Blinatumomab Drugs Revenue Market Share by Type (2016-2026)
Figure 49. Global Blinatumomab Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 50. Global Blinatumomab Drugs Sales Market Share by Application (2016-2026)
Figure 51. Global Blinatumomab Drugs Revenue Market Share by Application (2016-2026)
Figure 52. Global Blinatumomab Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 53. North America Blinatumomab Drugs Sales Market Share by Country (2016-2026)
Figure 54. North America Blinatumomab Drugs Revenue Market Share by Country (2016-2026)
Figure 55. North America Blinatumomab Drugs Sales Market Share by Type (2016-2026)
Figure 56. North America Blinatumomab Drugs Sales Market Share by Application (2016-2026)
Figure 57. Europe Blinatumomab Drugs Sales Market Share by Country (2016-2026)
Figure 58. Europe Blinatumomab Drugs Revenue Market Share by Country (2016-2026)
Figure 59. Europe Blinatumomab Drugs Sales Market Share by Type (2016-2026)
Figure 60. Europe Blinatumomab Drugs Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Blinatumomab Drugs Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Blinatumomab Drugs Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Blinatumomab Drugs Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Blinatumomab Drugs Sales Market Share by Application (2016-2026)
Figure 65. South America Blinatumomab Drugs Sales Market Share by Country (2016-2026)
Figure 66. South America Blinatumomab Drugs Revenue Market Share by Country (2016-2026)
Figure 67. South America Blinatumomab Drugs Sales Market Share by Type (2016-2026)
Figure 68. South America Blinatumomab Drugs Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Blinatumomab Drugs Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Blinatumomab Drugs Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Blinatumomab Drugs Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Blinatumomab Drugs Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source
世界のブリナツモマブ市場 2021：企業別、地域別、種類・用途別 The Blinatumomab market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recen…- 世界のペグアスパラガーゼ薬市場 2021：企業別、地域別、種類・用途別 The Pegaspargase Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
- 世界のイロプロスト薬市場規模・現状・予測（2021年-2027年） Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon and other diseases in which the blood vessels are constricted and blood can't flow to the tissues. North America is estimated to have a major share in the global market with 75%. Market Analysis…
- 世界のクロファラビン薬市場 2021：企業別、地域別、種類・用途別 The Clofarabine Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …
- 世界のメシル酸イマチニブ薬市場 2021：企業別、地域別、種類・用途別 The Imatinib Mesylate Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…